N-[2-(2-Benzofuran-2-yl-1H-indol-3-yl)-ethyl]-4-pentyl-benzenesulfonamide

ID: ALA179335

Chembl Id: CHEMBL179335

PubChem CID: 11248759

Max Phase: Preclinical

Molecular Formula: C29H30N2O3S

Molecular Weight: 486.64

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCc1ccc(S(=O)(=O)NCCc2c(-c3cc4ccccc4o3)[nH]c3ccccc23)cc1

Standard InChI:  InChI=1S/C29H30N2O3S/c1-2-3-4-9-21-14-16-23(17-15-21)35(32,33)30-19-18-25-24-11-6-7-12-26(24)31-29(25)28-20-22-10-5-8-13-27(22)34-28/h5-8,10-17,20,30-31H,2-4,9,18-19H2,1H3

Standard InChI Key:  NAGWGZLQLARBPK-UHFFFAOYSA-N

Associated Targets(Human)

ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX12 Tchem Arachidonate 12-lipoxygenase (3262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15 Tchem Arachidonate 15-lipoxygenase (7108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ALOX15 Arachidonate 15-lipoxygenase (2064 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 486.64Molecular Weight (Monoisotopic): 486.1977AlogP: 6.83#Rotatable Bonds: 10
Polar Surface Area: 75.10Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.38CX Basic pKa: CX LogP: 6.85CX LogD: 6.85
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.21Np Likeness Score: -0.50

References

1. Weinstein DS, Liu W, Gu Z, Langevine C, Ngu K, Fadnis L, Combs DW, Sitkoff D, Ahmad S, Zhuang S, Chen X, Wang FL, Loughney DA, Atwal KS, Zahler R, Macor JE, Madsen CS, Murugesan N..  (2005)  Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.,  15  (5): [PMID:15713402] [10.1016/j.bmcl.2004.12.081]
2. Rai G, Joshi N, Jung JE, Liu Y, Schultz L, Yasgar A, Perry S, Diaz G, Zhang Q, Kenyon V, Jadhav A, Simeonov A, Lo EH, van Leyen K, Maloney DJ, Holman TR..  (2014)  Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.,  57  (10): [PMID:24684213] [10.1021/jm401915r]
3. Eleftheriadis N, Neochoritis CG, Leus NG, van der Wouden PE, Dömling A, Dekker FJ..  (2015)  Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.,  58  (19): [PMID:26331552] [10.1021/acs.jmedchem.5b01121]

Source